Abstract C189: CO-1686, an orally available, mutant-selective inhibitor of the epidermal growth factor receptor (EGFR), causes tumor shrinkage in non-small cell lung cancer (NSCLC) with T790M mutations.

Name: Work Video:
Duration: 3 min 30 s
Annette O. Walter; Robert Tjin; Henry J. Haringsma; Kevin Lin; Alex Dubrovskiy; Kwangho Lee; Thia St Martin; Russell Karp; Zhendong Zhu; Deqiang Niu; Mariana Nacht; Russell C. Petter; William Westlin; Juswinder Singh; Mitch Raponi; Andrew R. Allen
{'id': 'https://openalex.org/W2097775552', 'doi': 'https://doi.org/10.1158/1535-7163.targ-11-c189', 'title': 'Abstract C189: CO-1686, an orally available, mutant-selective inhibitor of the epidermal growth factor receptor (EGFR), causes tumor shrinkage in non-small cell lung cancer (NSCLC) with T790M mutations.', 'display_name': 'Abstract C189: CO-1686, an orally available, mutant-selective inhibitor of the epidermal growth factor receptor (EGFR), causes tumor shrinkage in non-small cell lung cancer (NSCLC) with T790M mutations.', 'publication_year': 2011, 'publication_date': '2011-11-01', 'ids': {'openalex': 'https://openalex.org/W2097775552', 'doi': 'https://doi.org/10.1158/1535-7163.targ-11-c189', 'mag': '2097775552'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-11-c189', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5109225323', 'display_name': 'Annette O. Walter', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151488', 'display_name': 'Clovis Oncology (United States)', 'ror': 'https://ror.org/04ps4d441', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151488']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Annette O. Walter', 'raw_affiliation_strings': ['1Clovis Oncology, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Clovis Oncology, San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210151488']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048955746', 'display_name': 'Robert Tjin', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Robert Tjin', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048447647', 'display_name': 'Henry J. Haringsma', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151488', 'display_name': 'Clovis Oncology (United States)', 'ror': 'https://ror.org/04ps4d441', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151488']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Henry Haringsma', 'raw_affiliation_strings': ['1Clovis Oncology, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Clovis Oncology, San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210151488']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074764224', 'display_name': 'Kevin Lin', 'orcid': 'https://orcid.org/0000-0002-1236-9847'}, 'institutions': [{'id': 'https://openalex.org/I4210151488', 'display_name': 'Clovis Oncology (United States)', 'ror': 'https://ror.org/04ps4d441', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151488']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kevin Lin', 'raw_affiliation_strings': ['1Clovis Oncology, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Clovis Oncology, San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210151488']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023258446', 'display_name': 'Alex Dubrovskiy', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Alex Dubrovskiy', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100648421', 'display_name': 'Kwangho Lee', 'orcid': 'https://orcid.org/0000-0002-4216-7584'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kwangho Lee', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5107632011', 'display_name': 'Thia St Martin', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Thia St. Martin', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075742013', 'display_name': 'Russell Karp', 'orcid': 'https://orcid.org/0000-0002-3143-4114'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Russell Karp', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012261150', 'display_name': 'Zhendong Zhu', 'orcid': 'https://orcid.org/0000-0001-7002-7119'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zhendong Zhu', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108683735', 'display_name': 'Deqiang Niu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Deqiang Niu', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059593640', 'display_name': 'Mariana Nacht', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Mariana Nacht', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043971328', 'display_name': 'Russell C. Petter', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Russell C. Petter', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048225313', 'display_name': 'William Westlin', 'orcid': 'https://orcid.org/0000-0002-9080-1930'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'William F. Westlin', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022553023', 'display_name': 'Juswinder Singh', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Juswinder Singh', 'raw_affiliation_strings': ['2Avila Therapeutics, Bedford, MA.'], 'affiliations': [{'raw_affiliation_string': '2Avila Therapeutics, Bedford, MA.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018531947', 'display_name': 'Mitch Raponi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151488', 'display_name': 'Clovis Oncology (United States)', 'ror': 'https://ror.org/04ps4d441', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151488']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mitch Raponi', 'raw_affiliation_strings': ['1Clovis Oncology, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Clovis Oncology, San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210151488']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5065505740', 'display_name': 'Andrew R. Allen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151488', 'display_name': 'Clovis Oncology (United States)', 'ror': 'https://ror.org/04ps4d441', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210151488']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrew Allen', 'raw_affiliation_strings': ['1Clovis Oncology, San Francisco, CA;'], 'affiliations': [{'raw_affiliation_string': '1Clovis Oncology, San Francisco, CA;', 'institution_ids': ['https://openalex.org/I4210151488']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.857, 'has_fulltext': False, 'cited_by_count': 12, 'citation_normalized_percentile': {'value': 0.718003, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '10', 'issue': '11_Supplement', 'first_page': 'C189', 'last_page': 'C189'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9911, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9911, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/t790m', 'display_name': 'T790M', 'score': 0.92115116}], 'concepts': [{'id': 'https://openalex.org/C2777930144', 'wikidata': 'https://www.wikidata.org/wiki/Q25100112', 'display_name': 'T790M', 'level': 5, 'score': 0.92115116}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.81563723}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.64440453}, {'id': 'https://openalex.org/C143065580', 'wikidata': 'https://www.wikidata.org/wiki/Q3285695', 'display_name': 'Mutant', 'level': 3, 'score': 0.6374391}, {'id': 'https://openalex.org/C2779177807', 'wikidata': 'https://www.wikidata.org/wiki/Q3658562', 'display_name': 'non-small cell lung cancer (NSCLC)', 'level': 4, 'score': 0.5560992}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.55151784}, {'id': 'https://openalex.org/C501734568', 'wikidata': 'https://www.wikidata.org/wiki/Q42918', 'display_name': 'Mutation', 'level': 3, 'score': 0.45958534}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4484895}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.42475006}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3981964}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.36780676}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3210198}, {'id': 'https://openalex.org/C2780580887', 'wikidata': 'https://www.wikidata.org/wiki/Q417824', 'display_name': 'Gefitinib', 'level': 4, 'score': 0.28260225}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.2597033}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.25059348}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.1367665}, {'id': 'https://openalex.org/C81729549', 'wikidata': 'https://www.wikidata.org/wiki/Q4649475', 'display_name': 'A549 cell', 'level': 3, 'score': 0.11705515}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.114023745}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-11-c189', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.85, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3072989489', 'https://openalex.org/W3031530718', 'https://openalex.org/W3030729391', 'https://openalex.org/W3024742273', 'https://openalex.org/W2944067375', 'https://openalex.org/W2792211948', 'https://openalex.org/W2396646910', 'https://openalex.org/W2106937997', 'https://openalex.org/W2043552054', 'https://openalex.org/W1849518619'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction:': [1], 'Non-small': [2], 'cell': [3, 150, 199], 'lung': [4, 302], 'cancer': [5], '(NSCLC)': [6], 'patients': [7, 97], 'with': [8, 98, 108, 287, 306, 329, 335, 351], 'activating': [9, 64, 210, 336], 'EGFR': [10, 16, 45, 59, 65, 77, 99, 109, 153, 166, 202, 212, 220, 282, 296, 327, 337], 'mutations': [11, 66, 100, 338], 'initially': [12], 'respond': [13], 'well': [14, 68, 215, 340], 'to': [15, 55, 90, 186], 'tyrosine': [17], 'kinase': [18, 110], 'inhibitors.': [19], 'However,': [20], 'clinical': [21, 114], 'efficacy': [22, 332], 'is': [23, 36, 194, 298], 'limited': [24], 'by': [25, 171], 'the': [26, 70, 79, 88, 103, 208, 217, 246, 257, 288, 342, 379], 'development': [27], 'of': [28, 34, 44, 50, 81, 139, 165, 198, 234, 281, 378], 'resistance.': [29], 'The': [30], 'most': [31], 'common': [32], 'mechanism': [33], 'resistance': [35, 72, 343, 361], 'a': [37, 57, 85, 125, 195, 239, 323, 354], 'second': [38], 'site': [39], 'mutation': [40, 73, 211, 219, 344], 'within': [41], 'exon': [42], '20': [43], '(T790M),': [46], 'observed': [47, 289, 299], 'in': [48, 113, 142, 145, 147, 174, 204, 238, 284, 300, 330, 362], '∼50%': [49], 'cases.': [51], 'Our': [52, 318], 'goal': [53], 'was': [54, 184], 'develop': [56], 'mutant-selective': [58], 'inhibitor': [60, 197, 328], 'that': [61, 310, 349], 'potently': [62], 'inhibits': [63, 132], 'as': [67, 69, 214, 216, 322, 339, 341, 353], 'T790M': [71], 'while': [74, 292], 'sparing': [75, 326], 'wild-type': [76, 190, 315, 325], 'for': [78], 'treatment': [80, 350], 'NSCLC': [82, 96, 149, 205, 277], 'patients.': [83], 'Such': [84], 'drug': [86, 120, 360], 'has': [87], 'potential': [89], 'effectively': [91], 'treat': [92], 'first-': [93], 'and': [94, 144, 158, 168, 176, 201, 385], 'second-line': [95], 'without': [101, 251], 'causing': [102, 242], 'dose': [104, 248, 259], 'limiting': [105], 'toxicities': [106], 'associated': [107], 'inhibitors': [111], 'currently': [112], 'development.': [115], 'Experimental': [116], 'procedures:': [117], 'Using': [118], 'structure-based': [119], 'design,': [121], 'we': [122], 'identified': [123], 'CO-1686,': [124], 'covalent,': [126], 'irreversible': [127], 'small': [128], 'molecule,': [129], 'which': [130], 'selectively': [131], 'mutant': [133], 'EGFR.': [134, 191, 316], 'We': [135, 162], 'assessed': [136], 'antitumor': [137], 'activity': [138], 'CO-1686': [140, 193, 225, 307, 311, 321, 352], 'both': [141, 270, 276], 'vitro': [143], 'vivo': [146, 331], 'two': [148], 'lines': [151], 'harboring': [152, 207], 'mutations:': [154], 'H1975': [155, 235, 264], '(EGFR': [156, 160], 'L858R/T790M)': [157], 'HCC827': [159, 267], 'delE746-A750).': [161], 'evaluated': [163], 'inhibition': [164, 280], 'phosphorylation': [167, 283], 'downstream': [169], 'signaling': [170, 203, 297], 'immunoblot': [172], 'analysis': [173], 'cells': [175, 206, 236], 'tissue': [177], 'samples.': [178], 'IHC': [179], 'staining': [180], 'on': [181, 189, 295], 'skin': [182, 304], 'samples': [183], 'performed': [185], 'address': [187], 'effects': [188], 'Results:': [192], 'potent': [196], 'proliferation': [200], 'single': [209, 355], 'delE746-A750': [213], 'double': [218], 'L858R/T790M.': [221], 'When': [222], 'administered': [223], 'orally,': [224], '(3': [226], '−': [227], '100': [228], 'mg/kg)': [229, 250], 'significantly': [230], 'suppresses': [231], 'tumor': [232, 243, 273], 'growth': [233], '(L858R/T790M)': [237], 'dose-dependent': [240], 'manner': [241], 'regressions': [244], 'at': [245, 256], 'highest': [247], '(100': [249], 'affecting': [252], 'body': [253], 'weight.': [254], 'Erlotinib': [255], 'same': [258], 'exhibits': [260], 'no': [261, 293], 'effect': [262, 294], 'against': [263, 333], 'xenografts.': [265], 'In': [266, 275], '(delE746-A750)': [268], 'xenografts,': [269], 'agents': [271], 'cause': [272], 'shrinkage.': [274], 'mouse': [278], 'models,': [279], 'tumors': [285, 334], 'correlate': [286], 'anti-tumor': [290], 'activity,': [291], 'normal': [301], 'or': [303], 'tissues': [305], 'treatment,': [308], 'confirming': [309], 'does': [312], 'not': [313], 'inhibt': [314], 'Conclusions:': [317], 'results': [319], 'establish': [320], 'mutant-selective,': [324], 'T790M.': [345], 'These': [346], 'data': [347], 'suggest': [348], 'agent': [356], 'can': [357], 'overcome': [358], 'T790M-mediated': [359], 'NSCLC.': [363], 'This': [364], 'hypothesis': [365], 'will': [366], 'be': [367], 'tested': [368], 'clinically.': [369], 'Citation': [370], 'Format:': [371], '{Authors}.': [372], '{Abstract': [373], 'title}': [374], '[abstract].': [375], 'In:': [376], 'Proceedings': [377], 'AACR-NCI-EORTC': [380], 'International': [381], 'Conference:': [382], 'Molecular': [383], 'Targets': [384], 'Cancer': [386, 398], 'Therapeutics;': [387], '2011': [388], 'Nov': [389], '12-16;': [390], 'San': [391], 'Francisco,': [392], 'CA.': [393], 'Philadelphia': [394], '(PA):': [395], 'AACR;': [396], 'Mol': [397], 'Ther': [399], '2011;10(11': [400], 'Suppl):Abstract': [401], 'nr': [402], 'C189.': [403]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2097775552', 'counts_by_year': [{'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 7}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-12-24T14:24:49.748530', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
